Literature DB >> 4917709

Potentiation of a monoamine oxidase inhibitor by tryptophan.

A H Glassman, S R Platman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4917709     DOI: 10.1016/0022-3956(69)90013-2

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


× No keyword cloud information.
  15 in total

1.  Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

Authors:  R D Levitan; J H Shen; R Jindal; H S Driver; S H Kennedy; C M Shapiro
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Management of resistant depression.

Authors:  L Warneke
Journal:  Can Fam Physician       Date:  1996-10       Impact factor: 3.275

3.  Strategies for the drug treatment of depression.

Authors:  A J Cooper; R V Magnus
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

4.  The acute effects of oral (--)-tryptophan in human subjects.

Authors:  M H Greenwood; M H Lader; B D Kantameneni; G Curzon
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

Review 5.  Tryptophan antidepressant 'physiological sedative': fact or fancy?

Authors:  A J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

6.  Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 7.  Use of tryptophan in combination with other antidepressant treatments: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1991-12       Impact factor: 6.186

Review 8.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

9.  Uptake of 5-hydroxytryptamine in the catecholamine containing areas of the hypothalamus of the rat after treatment with phenelzine and tryptophan.

Authors:  G W Arbuthnott; D Eccleston; I Laszlo; N Nicolaou
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

10.  Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment.

Authors:  M van Wijk; J J Meisch; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1977-12-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.